Microbot Medical Inc..
MBOT.US | Manufacture of medical and dental instruments and supplies
Microbot Medical Inc. is a U.S.-based medical device company specializing in the design, development, and commercialization of micro-robotic endoluminal surgery devices. Their primary focus is on developing innovative solutions for minimally invasive surgical procedures, particularly in areas such a...Show More
Better Health for All
10
Microbot Medical's core product, the LIBERTY® Endovascular Robotic System, is entirely devoted to health improvement, demonstrating a 92% relative reduction in radiation exposure and 100% robotic navigation success in a 20-patient trial.
1
The company has no revenue from harmful products, as it is in the pre-commercialization stage with a business model focused on health benefits. The ACCESS-PVI trial reported no adverse device events (0%) in 20 patients.
2
However, the company's risk transparency is limited as the telesurgery feature, which could increase access to care, is not included in the pending FDA 510(k) submission, and the system is still an investigational device.
3
While the company is investing in telesurgery capabilities,
4
no specific percentage of R&D budget allocated to health improvement is provided. The potential to increase access to quality healthcare in remote locations is noted,
5
but there is no evidence of actual reach to vulnerable populations. The clinical trial was conducted at three leading medical centers in the U.S.,
6
but no further details on ethical conduct are provided.
Fair Money & Economic Opportunity
0
Microbot Medical Inc. is a pre-commercial medical technology company focused on developing and commercializing the LIBERTY® Endovascular Robotic System.
1
The company's core business is in medical devices, not financial services. As such, it does not offer lending, deposit, or other financial products to consumers, nor does it manage customer finance data or operate financial service access points. Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to Microbot Medical Inc.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles to assess Microbot Medical Inc. against any of the KPIs for Fair Pay & Worker Respect. The employment agreement detailed only one individual's contract without providing company-wide metrics, and the SEC filings were inaccessible, preventing data extraction.
1
Fair Trade & Ethical Sourcing
0
No specific, concrete evidence regarding MBOT.US's performance on Fair Trade & Ethical Sourcing KPIs was found in the provided articles.
1
All articles explicitly state a lack of relevant quantitative data or specific information for the company.
Honest & Fair Business
0
No evidence available to assess Microbot Medical Inc. on Honest & Fair Business.
Kind to Animals
-20
Microbot Medical Inc. conducts pre-clinical animal studies for its LIBERTY™ Robotic System.
1
Over 100 catheterizations were performed across multiple pre-clinical studies, including 48 in an extended joint study and 63 navigations in another study.
2
A feasibility animal study was successfully concluded on August 17, 2020, with no intraoperative adverse events.
3
The company plans further pre-clinical studies in the U.S. and other markets.
4
There is no evidence of any formal policy to restrict, reduce, or prohibit animal testing, nor any mention of ethical oversight or alternative methods.
No War, No Weapons
0
The provided article does not contain any specific, concrete evidence or metrics related to Microbot Medical Inc.'s involvement with arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other criteria relevant to the 'No War, No Weapons' ethical value.
1
Therefore, no KPIs can be scored based on the available information.
Planet-Friendly Business
10
The company reported annual carbon emissions of 18.3 metric tons CO2 equivalent.
1
It sources 45% of its operational energy consumption from renewables.
2
Water usage is 63.875 m³ per $1 million revenue, based on 6,750 gallons of water usage and $0.4 million in revenue for 2023.
3
In 2023, the company recorded 0 critical compliance violations.
4
Respect for Cultures & Communities
0
No specific, factual evidence was found in the provided articles regarding Microbot Medical Inc.'s performance on any of the KPIs related to Respect for Cultures & Communities. The articles either focused on unrelated topics, were from other organizations, or explicitly stated a lack of relevant data concerning community relations.
Safe & Smart Tech
0
The company has no documented incidents of unauthorized data use.
1
Zero Waste & Sustainable Products
-20
Microbot Medical Inc. incorporates recyclable components in 68% of its products.
1
The company has reported zero critical compliance violations related to waste disposal.
2